S

Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399

Watchlist Manager
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Watchlist
Price: 11.07 CNY -2.47% Market Closed
Market Cap: 13.8B CNY
Have any thoughts about
Shenzhen Hepalink Pharmaceutical Group Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Shenzhen Hepalink Pharmaceutical Group Co Ltd

Revenue
5.6B CNY
Cost of Revenue
-3.8B CNY
Gross Profit
1.8B CNY
Operating Expenses
-2B CNY
Operating Income
-150.1m CNY
Other Expenses
-92.8m CNY
Net Income
-242.9m CNY

Income Statement
Shenzhen Hepalink Pharmaceutical Group Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
1 478
N/A
1 719
+16%
1 959
+14%
2 387
+22%
2 251
-6%
2 141
-5%
2 292
+7%
2 223
-3%
2 279
+3%
2 318
+2%
2 261
-2%
2 045
-10%
2 218
+8%
2 486
+12%
2 843
+14%
3 347
+18%
3 892
+16%
4 307
+11%
4 815
+12%
4 879
+1%
4 749
-3%
4 622
-3%
4 625
+0%
5 004
+8%
5 155
+3%
5 028
-2%
5 332
+6%
5 198
-3%
5 786
+11%
6 421
+11%
6 365
-1%
7 008
+10%
7 010
+0%
7 129
+2%
7 159
+0%
6 550
-9%
6 114
-7%
5 827
-5%
5 446
-7%
5 518
+1%
5 570
+1%
Gross Profit
Cost of Revenue
(1 173)
(1 280)
(1 415)
(1 628)
(1 492)
(1 432)
(1 477)
(1 415)
(1 476)
(1 546)
(1 565)
(1 480)
(1 603)
(1 755)
(1 981)
(2 187)
(2 468)
(2 669)
(2 933)
(3 002)
(2 971)
(2 921)
(2 947)
(3 063)
(3 077)
(3 047)
(3 300)
(3 321)
(3 852)
(4 283)
(4 367)
(4 834)
(4 755)
(4 833)
(4 864)
(4 365)
(4 074)
(3 917)
(4 501)
(3 722)
(3 761)
Gross Profit
305
N/A
438
+44%
544
+24%
759
+40%
759
+0%
709
-7%
816
+15%
808
-1%
803
-1%
773
-4%
696
-10%
565
-19%
615
+9%
731
+19%
863
+18%
1 161
+35%
1 423
+23%
1 639
+15%
1 882
+15%
1 877
0%
1 778
-5%
1 701
-4%
1 678
-1%
1 941
+16%
2 078
+7%
1 981
-5%
2 032
+3%
1 877
-8%
1 935
+3%
2 137
+10%
1 998
-7%
2 173
+9%
2 255
+4%
2 296
+2%
2 296
0%
2 185
-5%
2 040
-7%
1 910
-6%
945
-51%
1 796
+90%
1 809
+1%
Operating Income
Operating Expenses
(282)
(306)
(330)
(374)
(343)
(345)
(324)
(463)
(466)
(479)
(376)
(458)
(504)
(526)
(702)
(719)
(770)
(815)
(884)
(936)
(927)
(988)
(917)
(952)
(974)
(939)
(996)
(978)
(1 018)
(1 057)
(1 187)
(1 450)
(1 498)
(1 577)
(1 293)
(1 341)
(1 364)
(1 278)
(1 233)
(2 019)
(1 959)
Selling, General & Administrative
(296)
(302)
(242)
(356)
(302)
(316)
(274)
(425)
(436)
(446)
(341)
(428)
(442)
(442)
(496)
(565)
(607)
(674)
(626)
(684)
(718)
(734)
(698)
(818)
(827)
(823)
(768)
(805)
(825)
(838)
(878)
(996)
(1 018)
(1 073)
(972)
(1 086)
(1 104)
(1 040)
(930)
(900)
(837)
Research & Development
0
0
(60)
0
0
0
(97)
0
0
0
(62)
0
0
(27)
(89)
(114)
(161)
(143)
(181)
(165)
(136)
(182)
(143)
(127)
(125)
(106)
(154)
(160)
(183)
(200)
(216)
(224)
(242)
(279)
(244)
(258)
(268)
(238)
(173)
(191)
(168)
Depreciation & Amortization
0
0
(20)
0
0
0
(30)
0
0
0
(63)
0
0
0
(73)
0
0
0
(83)
0
0
0
(93)
0
0
0
(101)
0
0
0
(101)
0
0
0
(93)
0
0
0
(101)
0
0
Other Operating Expenses
14
(3)
(9)
(18)
(41)
(28)
77
(38)
(31)
(33)
90
(30)
(63)
(57)
(45)
(41)
(2)
2
6
(88)
(72)
(72)
16
(7)
(21)
(10)
27
(13)
(10)
(20)
8
(229)
(238)
(225)
17
3
9
(0)
(28)
(928)
(955)
Operating Income
23
N/A
133
+489%
214
+61%
385
+80%
416
+8%
365
-12%
492
+35%
345
-30%
337
-2%
294
-13%
320
+9%
107
-66%
111
+3%
205
+85%
160
-22%
442
+175%
653
+48%
824
+26%
999
+21%
941
-6%
852
-9%
713
-16%
760
+7%
989
+30%
1 105
+12%
1 042
-6%
1 036
-1%
899
-13%
916
+2%
1 080
+18%
811
-25%
723
-11%
757
+5%
719
-5%
1 003
+39%
844
-16%
677
-20%
632
-7%
(288)
N/A
(224)
+22%
(150)
+33%
Pre-Tax Income
Interest Income Expense
205
179
176
151
161
229
152
292
271
201
116
82
25
(22)
(70)
(229)
(280)
(288)
(244)
232
181
220
552
47
279
347
294
308
137
(41)
(356)
(390)
(312)
(204)
(193)
(223)
(312)
(462)
(491)
(512)
(89)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
1
2
1
(62)
0
3
3
3
3
0
(0)
0
0
2
2
(229)
(5)
(7)
(6)
19
(3)
(2)
(4)
(83)
(2)
(3)
Gain/Loss on Disposition of Assets
(1)
(1)
(0)
0
(1)
0
(0)
(0)
0
(0)
(0)
0
0
0
(2)
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
4
3
7
8
8
15
47
46
47
44
40
38
36
31
14
15
18
22
10
9
7
4
0
0
(1)
(1)
(2)
(2)
(5)
(8)
(4)
(6)
(2)
0
2
6
6
4
(67)
(87)
(87)
Pre-Tax Income
231
N/A
314
+36%
397
+27%
543
+37%
585
+8%
608
+4%
691
+14%
682
-1%
655
-4%
539
-18%
475
-12%
228
-52%
171
-25%
214
+25%
104
-51%
228
+119%
392
+72%
557
+42%
702
+26%
1 181
+68%
1 042
-12%
940
-10%
1 315
+40%
1 039
-21%
1 383
+33%
1 388
+0%
1 328
-4%
1 205
-9%
1 050
-13%
1 034
-2%
222
-78%
323
+45%
436
+35%
510
+17%
830
+63%
625
-25%
369
-41%
170
-54%
(928)
N/A
(825)
+11%
(328)
+60%
Net Income
Tax Provision
(57)
(66)
(61)
(93)
(87)
(83)
(123)
(107)
(103)
(85)
(89)
(48)
(43)
(51)
95
57
28
(3)
(134)
(190)
(159)
(144)
(271)
(236)
(293)
(294)
(306)
(295)
(271)
(261)
11
3
(29)
(83)
(115)
(79)
(42)
37
126
111
67
Income from Continuing Operations
174
247
335
450
498
525
568
575
551
454
386
180
129
163
199
285
420
553
568
991
883
796
1 044
804
1 090
1 094
1 022
910
779
772
233
326
407
426
715
545
327
207
(802)
(714)
(262)
Income to Minority Interest
3
3
3
3
5
8
12
15
14
12
11
9
12
13
(2)
(7)
(4)
11
23
38
31
16
16
4
4
3
3
3
2
5
7
6
6
5
12
13
13
11
19
19
19
Net Income (Common)
177
N/A
250
+41%
338
+35%
453
+34%
503
+11%
532
+6%
580
+9%
590
+2%
566
-4%
466
-18%
397
-15%
189
-52%
140
-26%
176
+26%
197
+12%
278
+41%
416
+50%
565
+36%
592
+5%
1 030
+74%
914
-11%
812
-11%
1 059
+30%
808
-24%
1 094
+35%
1 097
+0%
1 024
-7%
912
-11%
781
-14%
777
-1%
241
-69%
332
+38%
414
+25%
432
+4%
727
+69%
559
-23%
339
-39%
218
-36%
(783)
N/A
(695)
+11%
(243)
+65%
EPS (Diluted)
0.14
N/A
0.2
+43%
0.26
+30%
0.35
+35%
0.39
+11%
0.41
+5%
0.45
+10%
0.46
+2%
0.44
-4%
0.36
-18%
0.32
-11%
0.14
-56%
0.1
-29%
0.13
+30%
0.16
+23%
0.22
+38%
0.33
+50%
0.45
+36%
0.47
+4%
0.82
+74%
0.73
-11%
0.65
-11%
0.85
+31%
0.64
-25%
0.87
+36%
0.78
-10%
0.7
-10%
0.62
-11%
0.54
-13%
0.54
N/A
0.16
-70%
0.23
+44%
0.28
+22%
0.29
+4%
0.5
+72%
0.38
-24%
0.23
-39%
0.15
-35%
-0.53
N/A
-0.47
+11%
-0.17
+64%

See Also

Discover More